The Oswaldo Cruz Foundation, the Institut Pasteur and the University of São Paulo met on Friday 13 December 2024 to decide on the projects submitted under the 2024 Call for Proposals.
Taking into account the world's scientific priorities, the strategic priorities of each institute, the financial and temporal feasibility of the projects and the long-term impact of the possible results of the projects, the selection committee agreed to support 2 projects:
- Development of rapid molecular tests for the diagnosis of endemic fungal meningitis, whose co-PIs are:
- Rosely Maria Zancopé Oliveira (INI) for FIOCRUZ
- Dea Garcia-Hermoso (NRCMA/Translational Mycology Group) from the Institut Pasteur for the Pasteur Network
- Gil Benard (FM-USP) for USP
- Innovative Antiviral Candidates for COVID-19: In Vitro and In Vivo Evaluation of High-Affinity Derivatives whose co-PIs are:
- Aline da Rocha Matos (IOC) for FIOCRUZ
- Leo Poon (HKU-Pasteur) for the Pasteur Network
- Sabrina Epiphanio (FCF-USP) for USP
Each of the two projects will be supported €45,000 for the period January 2025 - December 2026.
This call for proposals involves the Oswaldo Cruz Foundation (Fiocruz), the Pasteur Network and the University of São Paulo (USP).
The new application deadline 2025 will be announced in September.
Consult the details of the call 2024
Consult the Application form 2024
